日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Engineered Ultrasmall Nanoparticle Drug-Immune Conjugates with "Hit and Run" Tumor Delivery to Eradicate Gastric Cancer

工程化超小纳米颗粒药物免疫结合物与“打击即跑”肿瘤输送技术一起根除胃癌

Li Zhang, Virginia Aragon-Sanabria, Anusha Aditya, Marcello Marelli, Tianye Cao, Feng Chen, Barney Yoo, Kai Ma, Li Zhuang, Thais Cailleau, Luke Masterson, Melik Z Turker, Rachel Lee, Gabriel DeLeon, Sebastien Monette, Raffaele Colombo, Ronald J Christie, Pat Zanzonico, Ulrich Wiesner, J Anand Subram

Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus

针对口蹄疫病毒开发的整合素 αvβ6 特异性胰腺癌疗法

Kate M Moore, Ami Desai, Bea de Luxán Delgado, Sara Maria David Trabulo, Claire Reader, Nicholas F Brown, Elizabeth R Murray, Adam Brentnall, Philip Howard, Luke Masterson, Francesca Zammarchi, John A Hartley, Patrick H van Berkel, John F Marshall

Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer

使用工程抗体和双马来酰亚胺吡咯并苯二氮卓二聚体制备的药物抗体比为 1 的均质抗体-药物偶联物的设计和表征

Jason B White, Ryan Fleming, Luke Masterson, Ben T Ruddle, Haihong Zhong, Christine Fazenbaker, Patrick Strout, Kim Rosenthal, Molly Reed, Vanessa Muniz-Medina, Philip Howard, Rakesh Dixit, Herren Wu, Mary Jane Hinrichs, Changshou Gao, Nazzareno Dimasi